Immuneering Corp is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMRX is expected to report earnings to -40 cents per share on November 06
Q3'25
Est.
$-0.40
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.05
Q4'24
Missed
by $0.13
Q3'24
Beat
by $0.06
The last earnings report on August 13 showed earnings per share of -40 cents, beating the estimate of -41 cents. With 6.01M shares outstanding, the current market capitalization sits at 510.97M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMRX showed earnings on August 13, 2025. You can read more about the earnings report here.